Oral Fluvoxamine Plus Budesonide Cuts Severe Disease in COVID-19
Reduction in incidence of severe disease requiring advanced care seen among high-risk outpatients with COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.